Maintenance of Certification Committee

Timothy K. Brennan, MD MPH

Dr. Brennan is the Vice President for Medical and Academic Affairs at the American College of Academic Addiction Medicine and ABAM. He is passionate about expanding high-quality and financially sustainable academic addiction medicine fellowship training around the United States. Dr. Brennan works with emerging and established fellowship programs from inception to accreditation. Additionally, he is the Director of the Addiction Institute at Mount Sinai West and Mount Sinai St. Luke’s Hospitals and the Program Director of the Fellowship in Addiction Medicine Program at the Icahn School of Medicine Mount Sinai in New York City. Dr. Brennan has spoken at state, national and international levels about addiction policy issues, particularly as related to young adults. He is the co-editor of Lippincott’s Essentials of Addiction Medicine and was appointed by Governor Cuomo to serve on the Medical Review Board at the New York State Justice Center. Dr. Brennan is Board Certified in pediatrics by the American Board of Pediatrics and Board Certified in addiction medicine by the American Board of Preventive Medicine.

Patrick G. O'Connor

Patrick G. O'Connor, MD MPH

Dr. O'Connor is the Dan Adams and Amanda Adams Professor and Chief of General Internal Medicine at Yale University School of Medicine and Yale-New Haven Hospital in New Haven, Connecticut. Dr. O'Connor's research and scholarly work have focused on the interface between primary care and substance abuse. He has written well over 200 papers on these topics that have been published in leading medical journals including The New England Journal of Medicine and JAMA. Dr. O'Connor's work in the area of opiate detoxification led to research examining the efficacy of opioid maintenance therapy for treating opioid use disorder in primary care and other general medical settings. He and his colleagues at Yale completed a series of studies that look at the effectiveness of methadone and of buprenorphine as the pharmacological agent for this treatment in primary care and emergency medicine settings. Among his accomplishments as Chief of General Internal Medicine at Yale is the recruitment of several academic "generalist" faculty to join efforts to perform research on a broad range of topics related to addiction medicine. The overall goal of this research is to improve access to treatment for patients with substance use disorders to high quality care for their substance use disorders in the context of their general medical care. Dr. O'Connor is also Past President of both the American Board of Addiction Medicine and AMERSA.

Jeffrey H. Samet

Jeffrey H. Samet, MD MA MPH

Dr. Samet is a graduate of Brandeis University and Baylor College of Medicine. He trained in Internal Medicine including chief residency at Boston City Hospital, Boston University School of Medicine (BUSM), and in a research fellowship at the Massachusetts General Hospital. He has been a primary care physician in Boston since 1983. Dr. Samet is the John Noble Professor of General Internal Medicine at BUSM and Professor of Community Health Sciences at the Boston University School of Public Health. He has been Chief of General Internal Medicine at BUSM/Boston Medical Center since 2002. Dr. Samet has a longstanding commitment to educating physicians about substance use disorders leading NIDA R-25 programs funding the Research in Addiction Medicine Scholars (RAMS) Program and the Chief Resident Immersion Training (CRIT) Program in addiction medicine. He was President of AMERSA (1999-2001), a member of the Institute of Medicine Committee on "Addressing the Quality Chasm in Mental Health and Addictive Disorders" (2004-2006) and President of the American Board of Addiction Medicine (2012-2013). His research interests addressing HIV and substance use and the integration of addiction treatment into mainstream medical care have been supported by NIDA and NIAAA for over 2 decades.

Robert J. Sokol

Robert J. Sokol, MD

Dr. Sokol is Emeritus Distinguished Professor in the Departments of Obstetrics and Gynecology and Physiology and Emeritus Dean of the Wayne State University School of Medicine and Adjunct Professor, in the Department of Epidemiology and Biostatistics of the Michigan State University College of Human Medicine. At Wayne State he served as Chair of the Departments of OB-GYN and of Translational Medicine and as Director of the C.S. Mott Center for Human Growth and Development, as well as Senior Vice President for Medical Affairs for the Detroit Medical Center. Among other honors, he was elected President of the Society for Maternal-Fetal Medicine, the Central Association of Obstetricians and Gynecologists, the Detroit Medical Academy and the Wayne State University Academy of Scholars. He chaired the Liaison Committee for Obstetrics and Gynecology and is Editor-in-Chief of ACOG Update, a monthly CME publication. Dr. Sokol has published extensively on the prevention of perinatal brain damage, particularly as it relates to prenatal exposure to alcohol and cocaine. His honors include many national research awards, a lifetime achievement award from the Society of Maternal-Fetal Medicine and awards from the Wayne State University School of Medicine student body, alumni and school. Dr. Sokol has authored almost 1600 publications, including nearly 400 referenced papers. He has served on four boards of directors of professional theaters, one of which he has chaired, three medical school/university boards, one of which he chaired and serves on many other boards and committees.